---
figid: PMC7761926__cancers-12-03638-g001
figtitle: General view of canonical and non-canonical Wnt signaling
organisms:
- Danio rerio
- Xenopus laevis
- Homo sapiens
- Mus musculus
- Drosophila melanogaster
- Lareunionomyces loeiensis
- Mouse mammary tumor virus
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
- Drosophila melanogaster
- Xenopus laevis
pmcid: PMC7761926
filename: cancers-12-03638-g001.jpg
figlink: pmc/articles/PMC7761926/figure/cancers-12-03638-f001/
number: F1
caption: General view of canonical and non-canonical Wnt signaling. The switch of
  the canonical Wnt/β-catenin signaling pathway depends on the subcellular location
  of β-catenin. The stability of β-catenin is controlled by the destruction complex,
  consisting of AXIN, APC, CK1, and GSK3. In the absence of WNT ligands, cytoplasmic
  β-catenin is first phosphorylated by CK1 at Ser45 residue, followed by GSK3 phosphorylation
  at the Thr41, Ser37, and Ser33 residues. Next, the phosphorylated motif of β-catenin
  acts as a docking site for βTrCP, which induces the final ubiquitin-mediated degradation
  of β-catenin (Wnt off). When WNT ligands bind to Frizzled receptors (FZDs) and low
  density lipoprotein receptor-related protein co-receptor 5/6 (LRP 5/6), the destruction
  complex is recruited to the plasma membrane, triggering the translocation of β-catenin
  into the nucleus and activating its downstream target genes via binding directly
  to the TCF/LEF transcription factor family (Wnt on). Wnt/PCP signaling involves
  the triggering of a cascade that contains small GTPases RHOA (transforming protein
  RhoA) and Ras-related C3 botulinum toxin substrate 1 (RAC1), activating Rho-associated
  protein kinases (ROCKs) and JUN N-terminal kinases, respectively. Wnt/Ca2+signaling
  involves the activation of phospholipase C, which in turn triggers the release of
  Ca2+ from intracellular stores and the activation of effectors such as calcium-
  or calmodulin-dependent protein kinase II, protein kinase C, and calcineurin (CaN).
  Next, CaN activates the nuclear factor of activated T cells, activating the transcription
  of downstream target genes.
papertitle: 'Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present
  and Evolving Views.'
reftext: Moon Jong Kim, et al. Cancers (Basel). 2020 Dec;12(12):3638.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9547636
figid_alias: PMC7761926__F1
figtype: Figure
redirect_from: /figures/PMC7761926__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7761926__cancers-12-03638-g001.html
  '@type': Dataset
  description: General view of canonical and non-canonical Wnt signaling. The switch
    of the canonical Wnt/β-catenin signaling pathway depends on the subcellular location
    of β-catenin. The stability of β-catenin is controlled by the destruction complex,
    consisting of AXIN, APC, CK1, and GSK3. In the absence of WNT ligands, cytoplasmic
    β-catenin is first phosphorylated by CK1 at Ser45 residue, followed by GSK3 phosphorylation
    at the Thr41, Ser37, and Ser33 residues. Next, the phosphorylated motif of β-catenin
    acts as a docking site for βTrCP, which induces the final ubiquitin-mediated degradation
    of β-catenin (Wnt off). When WNT ligands bind to Frizzled receptors (FZDs) and
    low density lipoprotein receptor-related protein co-receptor 5/6 (LRP 5/6), the
    destruction complex is recruited to the plasma membrane, triggering the translocation
    of β-catenin into the nucleus and activating its downstream target genes via binding
    directly to the TCF/LEF transcription factor family (Wnt on). Wnt/PCP signaling
    involves the triggering of a cascade that contains small GTPases RHOA (transforming
    protein RhoA) and Ras-related C3 botulinum toxin substrate 1 (RAC1), activating
    Rho-associated protein kinases (ROCKs) and JUN N-terminal kinases, respectively.
    Wnt/Ca2+signaling involves the activation of phospholipase C, which in turn triggers
    the release of Ca2+ from intracellular stores and the activation of effectors
    such as calcium- or calmodulin-dependent protein kinase II, protein kinase C,
    and calcineurin (CaN). Next, CaN activates the nuclear factor of activated T cells,
    activating the transcription of downstream target genes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Rspo1
  - Lgr5
  - Lrp6
  - Lrp5
  - Ror2
  - Rora
  - Ror1
  - Znrf3
  - Rnf43
  - Dvl1
  - Hspg2
  - Axin1
  - Gm12892
  - Daam1
  - Rac1
  - Gsk3b
  - Btrc
  - Ctnnb1
  - Rhoa
  - Mapk8
  - Cdc42
  - Camk2a
  - Camk2b
  - Ep300
  - Crebbp
  - Pag1
  - Cytip
  - Atf2
  - Jun
  - pcp
  - Bmp1
  - Pgpep1
  - Prcp
  - Apc
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LGR5
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - LRP6
  - LRP5
  - ROR2
  - RORA
  - ROR1
  - LINC-ROR
  - ZNRF3
  - RNF43
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - AXIN1
  - AXIN2
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - DAAM1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - RAC1
  - RNASE1
  - GSK3B
  - BTRC
  - CTNNB1
  - RHOA
  - MAPK8
  - MAPK9
  - MAPK10
  - CDC42
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - CAMK2G
  - ROCK1
  - ROCK2
  - EP300
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - HNF4A
  - ATF2
  - GDNF
  - JUN
  - JUNB
  - JUND
  - BMP1
  - PRCP
  - PGPEP1
  - APC
  - PROC
  - lrp6
  - lrp5
  - ror2
  - ror1
  - znrf3
  - rnf43
  - daam1a
  - rac1a
  - gsk3ba
  - ctnnb1
  - rhoaa
  - rhoab
  - mapk8b
  - cdc42
  - cdc42l
  - elk4
  - atf2
  - jun
  - apc
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - fz
  - arr
  - Nrk
  - Ror
  - dsh
  - norpA
  - sl
  - Plc21C
  - Axn
  - CkIalpha
  - gish
  - DAAM
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Rac2
  - sgg
  - gskt
  - ca
  - slmb
  - arm
  - Rho1
  - bsk
  - NFAT
  - CaMKII
  - Rok
  - osa
  - nej
  - CBP
  - eIF4E1
  - pan
  - Atf-2
  - CG44247
  - Jra
  - Pcp
  - Apc2
  - Fs(3)Apc
  - lgr5.L
  - lrp6.L
  - lrp6.S
  - lrp5.L
  - ror2.L
  - znrf3.S
  - dvl2.L
  - dvl2.S
  - hspg2.L
  - axin1.S
  - csnk1a1.L
  - krt8.1.S
  - csnk1a1.S
  - krt8.1.L
  - daam1.S
  - daam1.L
  - rac3.S
  - rac1.L
  - gsk3b.L
  - gsk3b.S
  - btrc.S
  - btrc.L
  - ctnnb1.S
  - ctnnb1.L
  - rhoa.L
  - mapk8.L
  - mapk8.S
  - cdc42.L
  - nfatc3.S
  - nfatc2.L
  - nfatc2.S
  - nfatc3.L
  - camk2g.S
  - camk2g.L
  - crebbp.S
  - crebbp.L
  - ep300.L
  - ep300.S
  - atf2.S
  - jun.S
  - jun.L
  - apc.L
  - Ca
  - CaN
  - Ca2+
  - ARS
---
